Manganese superoxide dismutase vs. p53: Regulation of mitochondrial ROS

Mitochondrion

Volumn 10, Issue 6, 2010, Pages 649-661

  Holley, Aaron K ^a   Dhar, Sanjit Kumar ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Manganese superoxide dismutase; Mitochondria; P53; Reactive oxygen species

Indexed keywords

ACONITATE HYDRATASE; CATALASE; CELL NUCLEUS DNA; DIHYDROOROTATE DEHYDROGENASE; DNA DIRECTED DNA POLYMERASE GAMMA; DOXORUBICIN; GENE PRODUCT; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; OXOGLUTARATE DEHYDROGENASE; PHOSPHOGLYCERATE MUTASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROTEIN P53; PROTEIN SCO2; PROTEIN TIGAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REGULATOR PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; SYNTHESIS OF CYTOCHROME C OXIDASE 2 PROTEIN; TP53 INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AEROBIC CAPACITY; AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; ANTIOXIDANT CAPACITY; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL METABOLISM; CELL MOTILITY; CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; DNA METHYLATION; EXCISION REPAIR; EXERCISE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GLYCOLYSIS; HUMAN; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NITRATION; NONHUMAN; OLIGOMERIZATION; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN GLUTATHIONYLATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN OXIDATION; PROTEIN POLYMORPHISM; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; WARBURG EFFECT;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78149361937     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.06.003     Document Type: Review

References (261)

1. Abate C., Patel L., Rauscher F.J., Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990, 249:1157-1161.
2. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA pol gamma. EMBO J. 2005, 24:3483-3492.
3. Adams J.M. Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003, 17:2481-2495.
4. Andreyev A.Y., Kushnareva Y.E., Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Moscow) 2005, 70:246-264.
5. Arachiche A., Augereau O., Decossas M., Pertuiset C., Gontier E., Letellier T., Dachary-Prigent J. Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences. J. Biol. Chem. 2008, 283:24406-24411.
6. Assaily W., Benchimol S. Differential utilization of two ATP-generating pathways is regulated by p53. Cancer Cell 2006, 4-6.
7. Bakhanashvili M., Grinberg S., Bonda E., Rahav G. Excision of nucleoside analogs in mitochondria by p53 protein. AIDS 2009, 23:779-788.
8. Behrend I., Henderson G., Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 2003, 31:1441-1444.
9. Bendesky A., Rosales A., Salazar A.M., Sordo M., Peniche J., Ostrosky-Wegman P. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat. Res. 2007, 619:38-44.
10. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N.C., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
11. Berdanier C.D., Everts H.B., Hermoyian C., Mathews C.E. Role of vitamin A in mitochondrial gene expression. Diab. Res. Clin. Pract. 2001, 54:S11-S27.
12. Bolshakov S., Walker C.M., Strom S.S., Selvan M.S., Clayman G.L., El-Naggar A., Lippman S.M., Kripke M.L., Ananthaswamy H.N. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin. Cancer Res. 2003, 9:228-234.
13. Boonstra J., Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004, 337:1-13.
14. Bowsher C.G., Tobin A.K. Compartmentation of metabolism within mitochondria and plastids. J. Exp. Bot. 2001, 53:513-527.
15. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.-S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol 2004, 287:817-833.
16. Brown M.S., Stemmer S.M., Simon J.H., Stears J.C., Jones R.B., Cagnoni P.J., Sheeder J.L. White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am. J. Neuroradiol. 1998, 19:217-221.
17. Bui T., Thompson C.B. Cancer's sweet tooth. Cancer Cell 2006, 9:419-420.
18. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schroder E., Browning D.D., Eaton P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397.
19. Buzek J., Latonen L., Kurki S., Peltonen K., Laiho M. Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine-277. Nucleic Acids Res. 2002, 30:2340-2348.
20. Cannino G., Di Liegro C.M., Rinaldi A.M. Nuclear-mitochondrial interaction. Mitochondrion 2007, 7:359-366.
21. Cardone L., Carlucci A., Affaitati A., Livigni A., De Cristofaro T., Garbi C., Varrone S., Ullrich A., Gottesman M.E., Avvedimento E.V., Feliciello A. Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling. Mol. Cell. Biol. 2004, 24:4613-4626.
22. Carew J.S., Zhou Y., Albitar M., Carew J.D., Keating M.J., Huang P. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 2003, 17:1437-1447.
23. Casas F., Domenjoud L., Rochard P., Hatier R., Rodier A., Daury L., Bianchi A., Kremarik-Bouillaud P., Becuwe P., Keller J.-M., Schohn H., Wrutniak-Cabello C., Cabello G., Dauca M. A 45kDa protein related to PPARgamma2 induced by peroxisome proliferators, is located in the mitochondrial matrix. FEBS Lett. 2000, 478:4-8.
24. Casas F., Daury L., Grandemange S., Busson M., Seyer P., Hatier R., Carazo A., Cabello G., Wrutniak-Cabello C. Endocrine regulation of mitochondrial activity: involvement of truncated RXRalpha and c-Erb Aalpha1 proteins. FASEB J. 2003, 17:426-436.
25. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 1996, 328:309-316.
26. Castro L., Rodriquez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 1994, 269:29409-29415.
27. Chandel N.S., Schumacker P.T. Cellular oxygen sensing by mitochondria: old questions, new insight. J. Appl. Physiol. 2000, 88:1880-1889.
28. Chandel N.S., Vander Heiden M.G., Thompson C.B., Schumacker P.T. Redox regulation of p53 during hypoxia. Oncogene 2000, 19:3840-3848.
29. Chang T.-S., Cho C.-S., Park S., Yu S., Kang S.W. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulate apoptotic signaling by mitochondria. J. Biol. Chem. 2004, 279:41975-41984.
30. Chazotte-Aubert L., Hainaut P., Ohshima H. Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem. Biophys. Res. Commun. 2000, 267:609-613.
31. Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 2004, 61:192-208.
32. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 2003, 278:36027-36031.
33. Chen J.Z., Delannoy M., Cooke C., Yager J.D. Mitochondrial localization of ERa and ERb in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E1011-E1022.
34. Chen D., Yu Z., Zhu Z., Lopez C.D. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res. 2006, 66:3485-3494.
35. Chene P. Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro. Biochem. Biophys. Res. Commun. 1999, 263:1-5.
36. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
37. Chipuk J.E., Bouchier-Hayes L., Kuwana T., Newmeyer D.D., Green D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309:1732-1735.
38. Choi J.H., Kim T.N., Kim S., Baek S.H., Kim J.H., Lee S.R., Kim J.R. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinoma. Anticancer Res. 2002, 22:3331-3335.
39. Chuikov S., Kurash J.K., Wilson J.R., Xiao B., Justin N., Ivanov G.S., McKinney K., Tempst P., Prives C., Gamblin S.J., Barlev N.A., Danny R. Regulation of p53 activity through lysine methylation. Nat. Rev. Cancer 2004, 432:353-360.
40. Cobbs C.S., Whisenhunt T.R., Wesemann D.R., Harkins L.E., Van Meir E.G., Samanta M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003, 63:8670-8673.
41. Cobbs C.S., Samanta M., Harkins L.E., Gillespie G.Y., Merrick B.A., MacMillan-Crow L.A. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch. Biochem. Biophys. 2001, 394:167-172.
42. Cogswell P.C., Kashatus D.F., Keifer J.A., Guttridge D.C., Reuther J.Y., Bristow C., Roy S., Nicholson D.W., Baldwin J., Albert S. NF-kappaB and IkappaBalpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappaB. J. Biol. Chem. 2003, 278:2963-2968.
43. Copin J.-C., Gasche Y., Chan P.H. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic. Biol. Med. 2000, 28:1571-1576.
44. Corcoran C.A., Huang Y., Sheikh M.S. The regulation of energy generating metabolic pathways by p53. Cancer Biol. Ther. 2006, 5:1610-1613.
45. de Souza-Pinto N.C., Harris C.C., Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 2004, 23:6559-6568.
46. Delphin C., Cahen P., Lawrence J.J., Baudier J. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur. J. Biochem. 1994, 223:683-692.
47. Delsite R.L., Rasmussen L.J., Rasmussen A.K., Kalen A., Goswami P.C., Singh K.K. Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis 2003, 18:497-503.
48. Demonacos C.V., Karayanni N., Hatzoglou E., Tsiriyiotis C., Spandidos D.A., Sekeris C.E. Mitochondrial genes as sites of primary action of steroid hormones. Steroids 1996, 61:226-232.
49. Deng X., Gao F., May W.S. Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 2003, 102:3179-3185.
50. Dhar S.K., Xu Y., Chen Y., St.Clair D.K. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J. Biol. Chem. 2006, 281:21698-21709.
51. Dhar S.K., Xu Y., St.Clair D.K. Nuclear factor kB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. J. Biol. Chem. 2010, 285:9835-9846.
52. Di Domenico F., Cenini G., Sultana R., Perluigi M., Uberti D., Memo M., Butterfield D.A. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochem. Res. 2009, 34:727-733.
53. Drahota Z., Chowdhury S.K.R., Floryk D., Mracek T., Wilhelm J., Rauchova H., Lenaz G., Houstek J. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide. J. Bioenerg. Biomembr. 2002, 34:105-113.
54. Drane P., Bravard A., Bouvard V., May E. Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis. Oncogene 2001, 20:430-439.
55. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
56. Dumont P., Leu J.I.-J., Pietra A.C.D., George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003, 33:357-365.
57. Dumont M., Wille E., Stack C., Calingasan N.Y., Beal M.F., Lin M.T. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 2009, 23:2459-2466.
58. Duranteau J., Chandel N.S., Kulisz A., Shao Z., Schumacker P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 1998, 273:11619-11624.
59. Duttaroy A., Paul A., Kundu M., Belton A. A Sod2 null mutation confers severely reduced adult life span in Drosophila. Genetics 2003, 165:2295-2299.
60. Eaton S., Bartlett K., Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem. J. 1996, 320:345-357.
61. Esposito L., Raber J., Kekonius L., Yan F., Yu G.Q., Bien-Ly N., Puolivali J., Scearce-Levie K., Masliah E., Mucke L. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 2006, 26:5167-5179.
62. Esworthy R.S., Ho Y.-S., Chu F.-F. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch. Biochem. Biophys. 1997, 340:59-63.
63. 0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 2005, 24:4883-4893.
64. Fojta M., Kubicarova T., Vojtesek B., Palecek E. Effect of p53 protein redox states on binding to supercoiled and linear DNA. J. Biol. Chem. 1999, 274:25749-25755.
65. Fojta M., Pivonkova H., Brazdova M., Nemcova K., Palecek J., Vojtesek B. Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function. Eur. J. Biochem. 2004, 271:3865-3876.
66. Forman H.J., Kennedy J. Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid. J. Biol. Chem. 1975, 250:4322-4326.
67. Forman H.J., Kennedy J. Dihydroorotate-dependent superoxide production in rat brain and liver: a function of the primary dehydrogenase. Arch. Biochem. Biophys. 1976, 173:219-224.
68. Forman H.J., Maiorino M., Ursini F. Signaling functions of reactive oxygen species. Biochemistry 2010, 49:835-842.
69. Fridovich I. The biology of oxygen radicals. Science 1978, 201:875-880.
70. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 1989, 264:7761-7764.
71. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112.
72. 2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell. Physiol. Biochem. 2007, 20:45-54.
73. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., Sandaltzopoulos R. Reactive oxygen species and HIF-1 signaling in cancer. Cancer Lett. 2008, 266:12-20.
74. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
75. Genova M.L., Ventura B., Giuliano G., Bovina C., Formiggini G., Castelli G.P., Lenaz G. The site of production of superoxide radical in mitochondrial complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett. 2001, 505:364-368.
76. Ghezzi P. Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans. 2005, 33:1378-1381.
77. Giri S.N., Al-Bayati M.A., Du X., Schelegle E., Mohr F.C., Margolin S.B. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats. Cancer Chemother. Pharmacol. 2004, 53:141-150.
78. Gius D., Spitz D.R. Redox signaling in cancer biology. Antioxid. Redox Signal. 2006, 8:1249-1252.
79. Goldenthal M.J., Marin-Garcia J. Mitochondrial signaling pathways: a receiver/integrator organelle. Mol. Cell. Biochem. 2004, 262:1-16.
80. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
81. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994, 54:4855-4878.
82. Gregory E.M., Fridovich I. Oxygen toxicity and the superoxide dismutase. J. Bacteriol. 1973, 114:1193-1197.
83. Gregory E.M., Goscin S.A., Fridovich I. Superoxide dismutase and oxygen toxicity in a eukaryote. J. Bacteriol. 1974, 117:456-460.
84. Gulbins E., Dreschers S., Bock J. Role of mitochondria in apoptosis. Exp. Physiol. 2003, 88:85-90.
85. Hagn F., Klein C., Demmer O., Marchenko N., Veseva A., Moll U.M., Kessler H. BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem. 2010, 285:3439-3450.
86. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 1993, 53:4469-4473.
87. Haldar S., Negrini M., Monne M., Sabbioni S., Croce C.M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 1994, 54:2095-2097.
88. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J. 2001, 353:411-416.
89. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab. Rev. 2006, 38:171-196.
90. Harris S.L., Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899-2908.
91. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 1994, 269:29405-29408.
92. Herrero A., Barja G. Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J. Bioenerg. Biomembr. 2000, 32:609-615.
93. Hjalmarsson K., Marklund S.L., Engstrom A., Edlund T. Isolation and sequence of complimentary DNA encoding human extracellular superoxide dismutase. Proc. Natl. Acad. Sci. USA 1987, 84:6340-6344.
94. Hockenberry D.M., Oltval Z.N., Yin X.-M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
95. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., Harris C.C. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64:2350-2356.
96. Inoue M., Sato E.F., Nishikawa M., Park A.-M., Kira Y., Imada I., Utsumi K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr. Med. Chem. 2003, 10:2495-2505.
97. Itoh S., Lemay S., Osawa M., Che W., Duan Y., Tompkins A., Brookes P.S., Sheu S.-S., Abe J.-i. Mitochondrial Dok-4 recruits Src kinase and regulates NF-kB activation in endothelial cells. J. Biol. Chem. 2005, 280:26383-26396.
98. Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 2005, 7:395-403.
99. Kakkar P., Singh B.K. Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell. Biochem. 2007, 305:235-253.
100. 2 accumulation and radioresistance in human oral squamous carcinoma cells. Antioxid. Redox Signal. 2006, 8:1273-1281.
101. Karawajew L., Rhein P., Czerwony G., Ludwig W.-D. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 2005, 105:4767-4775.
102. Katsumoto T., Higaki K., Ohno K., Onodera K. Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol. Cell 1995, 84:167-173.
103. Keller J.N., Kindy M.S., Holtsberg F.W., St.Clair D.K., Yen H.-C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 1998, 18:687-697.
104. Kelner M.J., Montoya M.A. Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem. Biophys. Res. Commun. 2000, 269:366-368.
105. Kim J.-w., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006, 66:8927-8930.
106. Kim A., Zhong W., Oberley T.D. Reversible modulation of cell cycle kinetics in NIH/3T3 mouse fibroblasts by inducible overexpression of mitochondrial manganese superoxide dismutase. Antioxid. Redox Signal. 2004, 6:489-500.
107. Kim A., Joseph S., Khan A., Epstein C.J., Sobel R., Huang T.-T. Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin. Free Radic. Biol. Med. 2010, 48:1501-1512.
108. Klatt P., Molina E.P., de Locaba M.G., Padilla C.A., Martínez-Galisteo E., Bárcena J.A., Lamas S. Redox regulation of c-Jun DNA binding by reversible S-glutathionylation. FASEB J. 1999, 13:1481-1490.
109. Ko L.J., Prives C. p53: puzzle and paradigm. Genes Dev. 1996, 10:1054-1072.
110. Koehler C.M., Beverley K.N., Leverich E.P. Redox pathways of the mitochondrion. Antioxid. Redox Signal. 2006, 8:813-822.
111. Kokoszka J.E., Coskun P., Esposito L.A., Wallace D.C. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl. Acad. Sci. 2001, 98:2278-2283.
112. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
113. Koufali M.-M., Moutsatsou P., Sekeris C.E., Breen K.C. The dynamic localization of the glucocorticoid receptor in rat C6 glioma cell mitochondria. Mol. Cell. Endocrinol. 2003, 209:51-60.
114. Kulawiec M., Safina A., Desouki M.M., Still I., Matsui S.-I., Bakin A., Sing K.K. Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol. Ther. 2008, 7:1732-1743.
115. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8:8-16.
116. + oxidation-reduction state. Biochem. J. 2002, 368:545-553.
117. Lebedeva M.A., Eaton J.S., Shadel G. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787:328-334.
118. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., Huang S., Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA 1996, 93:9782-9787.
119. Lee S.-R., Kim J.-R., Kwon K.-S., Yoon H.W., Levine R.L., Ginsburg A., Rhee S.G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 1999, 274:4722-4734.
120. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001, 52:159-164.
121. Leu J.I.-J., Dumont P., Hafey M., Murphy M.E., George D.L. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 2004, 6:443-450.
122. Leverve X.M. Mitochondrial function and substrate availability. Crit. Care Med. 2007, 35:S454-S460.
123. Li Y., Huang T.-T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11.
124. Li Z., Shi K., Guan L., Cao T., Jiang Q., Yang Y., Xu C. ROS leads to MnSOD upregulation through ERK2 translocation and p53 activation in selenite-induced apoptosis of NB4 cells. FEBS Lett. 2010, 584:2291-2297.
125. Lin Y.-W., Lien L.-M., Yeh T.-S., Wu H.-M., Liu Y.-L., Hsieh R.-H. 9-cis retinoic acid induces retinoid X receptor localized to the mitochondria for mediation of mitochondrial transcription. Biochem. Biophys. Res. Commun. 2008, 377:351-354.
126. Liu M., Pelling J.C., Ju J., Chu E., Brash D.E. Antioxidant action via p53-mediated apoptosis. Cancer Res. 1998, 58:1723-1729.
127. Liu B., Chen Y., St.Clair D.K. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 2008, 44:1529-1535.
128. Liu J., St.Clair D.K., Gu X., Zhao Y. Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett. 2008, 582:1319-1324.
129. Livigni A., Scorziello A., Agnese S., Agnese S., Adornetto A., Carlucci A., Garbi C., Castaldo I., Annunziato L., Avvedimento E.V., Feliciello A. Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol. Biol. Cell 2006, 17:263-271.
130. Long X., Goldenthal M.J., Marin-Garcia J. Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 2007, 303:167-174.
131. Ma W., Sung H.J., Park J.Y., Matoba S., Hwang P.M. A pivotal role for p53: balancing aerobic respiration and glycolysis. J. Bioenerg. Biomembr. 2007, 39:243-246.
132. MacMillan-Crow L.A., Crow J.P., Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998, 37:1613-1622.
133. Maiorino M., Scapin M., Ursini F., Biasolo M., Bosello V., Flohe L. Distinct promoters determine alternative transcription of gpx-4 into phospholipid-hydroperoxide glutathione peroxidase variants. J. Biol. Chem. 2003, 278:34286-34290.
134. Mandal S., Guptan P., Owusu-Ansah E., Banerjee U. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev. Cell 2005, 9:843-854.
135. Manoli I., Alesci S., Blackman M.R., Su Y.A., Rennert O.M., Chrousos G.P. Mitochondria as key components of the stress response. Trends Endocrinol. Metab. 2007, 18:190-198.
136. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
137. Marcillat O., Zhang Y., Davies K.J.A. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem. J. 1989, 259:181-189.
138. Marcus D.L., Strafaci J.A., Freedman M.L. Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease. Med. Sci. Monit. 2006, 12:BR8-BR14.
139. Marshall H.E., Merchant K., Stamler J.S. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 2000, 14:1889-1900.
140. Matoba S., Kang J.-G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
141. Mazel S., Burtrum D., Petrie H.T. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 1996, 183:2219-2226.
142. McLennan H.R., Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 2000, 32:153-162.
143. Meng T.-C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 2002, 9:387-399.
144. Miao L., St.Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 2009, 47(4):344-356.
145. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
146. Mirza A., McGuirk M., Hockenberry T.N., Wu Q., Ashar H., Black S., Wen S.F., Wang L., Kirschmeier P., Bishop W.R., Nielsen L.L., Pickett C.B., Liu S. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002, 21:2613-2622.
147. 1-S regulates cyclin E buildup and entry into S phase. Proc. Natl. Acad. Sci. 2009, 106:11960-11965.
148. Miwa S., St.-Pierre J., Partridge L., Brand M.D. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic. Biol. Med. 2003, 35:938-948.
149. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
150. Moll U.M., Zaika A. Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett. 2001, 493:65-69.
151. Momand J., Wu H.-H., Dasgupta G. MDM-2-master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
152. Monteiro H.P., Arai R.J., Travassos L.R. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid. Redox Signal. 2008, 10:843-889.
153. Moutsatsou P., Psarra A.M.G., Tsiapara A., Paraskevakou H., Davaris P., Sekeris C.E. Localization of the glucocorticoid receptor in rat brain mitochondria. Arch. Biochem. Biophys. 2001, 386:69-78.
154. Mummenbrauer T., Janus F., Muller B., Wiesmuller L., Depert W., Grosse F. p53 protein exhibits 3'-to-5' exonuclease activity. Cell 1996, 85:1089-1099.
155. Murphy M.E. Polymorphic variants in the p53 pathway. Cell Death Differ. 2006, 13:916-920.
156. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
157. Murray J., Taylors S.W., Zhang B., Ghosh S.S., Capaldi R.A. Oxidative damage to mitochondrial complex I due to peroxynitrite. Identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 2003, 278:37223-37230.
158. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7:683-694.
159. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
160. Newsholme P., Bender K., Kiely A., Brennan L. Amino acid metabolism, insulin secretion and diabetes. Biochem. Soc. Trans. 2007, 35:1180-1186.
161. Nicholls D.G. Mitochondria and calcium signaling. Cell Calcium 2005, 38:311-317.
162. Nithipongvanitch R., Ittarat W., Velez J.M., Zhao R., St.Clair D.K., Oberley T.D. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J. Histochem. Cytochem. 2007, 55:629-639.
163. O'Reilly L.A., Huang D.C.S., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 1996, 15:6979-6990.
164. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 1979, 39:1141-1149.
165. Oberley T.D., Verwiebe E., Zhong W., Kang S.W., Rhee S.G. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 2001, 30:412-424.
166. Ogita K., Okuda H., Kitano M., Fujinami Y., Ozaki K., Yoneda Y. Localization of activator protein-1 complex with DNA binding activity in mitochondria of murine brain after in vivo treatment with kainate. J. Neurosci. 2002, 22:2561-2570.
167. Ohnishi T., Tamai I., Sakanaka K., Sakata A., Yamashima T., Yamashita J., Tsuji A. In vivo and in vitro evidence for ATP-dependency of p-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem. Pharmacol. 1995, 49:1541-1544.
168. Ohtsuka T., Ryu H., Minamishima Y.A., Macip S., Sagara J., Nakayama K.I., Aaronson S.A., Lee S.W. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat. Cell Biol. 2004, 6:121-128.
169. Okado-Matsumoto A., Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu, Zn-SOD in mitochondria. J. Biol. Chem. 2001, 276:38388-38393.
170. Oktyabrsky O.N., Smirnova G.V. Redox regulation of cellular functions. Biochemistry (Moscow) 2007, 72:132-145.
171. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 2003, 10:431-442.
172. Owusu-Ansah E., Yavari A., Mandal S., Banerjee U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat. Genet. 2008, 40:356-361.
173. Paddenberg R., Ishaq B., Goldenberg A., Faulhammer P., Rose F., Weissmann N., Braun-Dullaeus R.C., Kummer W. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L710-L719.
174. Padmaja S., Squadrito G.L., Pryor W.A. Inactivation of glutathione peroxidase by peroxynitrite. Arch. Biochem. Biophys. 1998, 349:1-6.
175. Pagliarini D.J., Wiley S.E., Kimple M.E., Dixon J.R., Kelly P., Worby C.A., Casey P.J., Dixon J.E. Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic β cells. Mol. Cell 2005, 19:197-207.
176. Panfili E., Sandri G., Ernster L. Distribution of glutathione peroxidases and glutathione reductase in rat brain mitochondria. FEBS Lett. 1991, 290:35-37.
177. Pani G., Bedogni B., Anzevino R., Colavitti R., Palazzotti B., Borrello S., Galeotti T. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res. 2000, 60:4654-4660.
178. Park S.Y., Chang I., Kim J.-Y., Kang S.W., Park S.-H., Singh K., Lee M.-S. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem. 2004, 279:7512-7520.
179. Park J.-Y., Wang P.-y., Matsumoto T., Sung H.J., Ma W., Choi J.W., Anderson S.A., Leary S.C., Balaban R.S., Kang J.-G., Hwang P.M. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ. Res. 2009, 105:705-712.
180. Paul A., Belton A., Nag S., Martin I., Grotewiel M.S., Duttaroy A. Reduced mitochondrial SOD displays mortality characteristics reminiscent of natural aging. Mech. Ageing Dev. 2007, 128:706-716.
181. Paulsen C.E., Carroll K.S. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem. Biol. 2010, 5:47-62.
182. Pelicano H., Lu W., Zhou Y., Zhang W., Chen Z., Hu Y., Huang P. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res. 2009, 69:2375-2383.
183. Petitjean A., Achatz M.I.W., Borresen-Dale A.L., Hainaut P., Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007, 26:2157-2165.
184. Pezeshki A., Sari-Aslani F., Ghaderi A., Doroudchi M. p53 codon 72 polymorphism in basal cell carcinoma of the skin. Pathol. Oncol. Res. 2006, 12:29-33.
185. Pietsch E.C., Humbey O., Murphy M.E. Polymorphisms in the p53 pathway. Oncogene 2006, 25:1602-1611.
186. Pineda-Molina E., Klatt P., Vázquez J., Marina A., De Locaba M.G., Pérez-Sala D., Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001, 40:14134-14142.
187. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E. Oxidative stress and cell signaling. Curr. Med. Chem. 2004, 11:1163-1182.
188. Prives C., Hall P.A. The p53 pathway. J. Pathol. 1999, 187:112-126.
189. Psarra A.-M.G., Sekeris C.E. Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment. Biochim. Biophys. Acta 2008, 1783:1-11.
190. Psarra A.M.G., Solakidi S., Sekeris C.E. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Ann. N.Y. Acad. Sci. 2006, 1088:12-22.
191. Radi R., Turrens J.F., Chang L.Y., Bush K.M., Crapo J.D., Freeman B.A. Detection of catalase in rat heart mitochondria. J. Biol. Chem. 1991, 266:22028-22034.
192. Radi R., Rodriquez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 1994, 308:89-95.
193. Radi R., Cassina A., Hodara R., Quijano C., Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 2002, 33:1451-1464.
194. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease, and ageing. TIBS 2000, 25:502-508.
195. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. (Semin. Med. Genet.) 2001, 106:62-70.
196. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., Mann K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 1995, 15:3892-3903.
197. Riobo N.A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., Poderoso J.J. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 2001, 359:139-145.
198. Robles A.I., Bemmels N.A., Foraker A.B., Harris C.C. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res. 2001, 61:6660-6664.
199. Ryan M.T., Hoogenraad N.J. Mitochondrial-nuclear communications. Annu. Rev. Biochem. 2007, 76:701-722.
200. 2+ signaling by ligand stimulated thyroid hormone receptor. J. Cell Biol. 2004, 167:915-924.
201. Salvi M., Stringaro A., Brunati A.M., Agostinelli E., Arancia G., Clair G., Toninello A. Tyrosine phosphatase activity in mitochondria: presence of Shp-2 phosphatase in mitochondria. Cell. Mol. Life Sci. 2004, 61:2393-2404.
202. Salvi M., Battaglia V., Brunati A.M., La Rocca N., Tibaldi E., Pietrangeli P., Marcocci L., Mondovi B., Rossi C.A., Toninello A. Catalase takes part in rat liver mitochondria oxidative stress defense. J. Biol. Chem. 2007, 282:24407-24415.
203. Sansome C., Zaika A., Marchenko N.D., Moll U.M. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett. 2001, 488:110-115.
204. Schafer M., Schafer C., Ewald N., Piper H.M., Noll T. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ. Res. 2003, 92:1010-1015.
205. Scheffler I.E. Mitochondria 1999, Wiley-Liss, Inc, New York.
206. Scheller K., Sekeris C.E., Krohne G., Hock R., Hansen I.A., Scheer U. Localization of glucocorticoid hormone receptors in mitochondria of human cells. Eur. J. Cell Biol. 2000, 79:299-307.
207. 1 phase cell cycle progression. Cell Cycle 2008, 7:1782-1787.
208. Senoo-Matsuda N., Yasuda K., Tsuda M., Ohkubo T., Yoshimura S., Nakazawa H., Hartman P.S., Ishii N. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 2001, 276:41553-41558.
209. Seo M.S., Kang S.W., Kim K., Baines I.C., Lee T.H., Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 2000, 275:20346-20354.
210. Seo Y.R., Kelley M.R., Smith M.L. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. USA 2002, 22:14548-14553.
211. Shibata E., Nanri H., Ejima K., Araki M., Fukuda J., Yoshimura K., Toki N., Ikeda M., Kashimura M. Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae. Placenta 2003, 24:698-705.
212. Silvagno F., de Vivo E., Attanasio A., Gallo V., Mazzucco G., Pescarmona G. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS ONE 2010, 5:e8670.
213. Singal P.K., Iliskovic N., Li T., Kumar D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 1997, 11:931-936.
214. Singh K.K., Kulawiec M., Still I., Desouki M.M., Geradts J., Matsui S.-I. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 2005, 354:140-146.
215. Singh K.K., Ayyasamy V., Owens K.M., Koul M.S., Vujcic M. Mutations in mitochondrial DNA polymerase-g promote breast tumorigenesis. J. Hum. Genet. 2009, 54:516-524.
216. Slot J.W., Geuze H.J., Freeman B.A., Crapo J.D. Intracellular localization of the copper-zinc and manganese superoxide dismutases in rat liver parenchymal cells. Lab. Invest. 1986, 55:363-371.
217. Smiraglia D.J., Kulawiec M., Bistulfi G.L., Gupta S.G., Singh K.K. A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol. Ther. 2008, 7:1182-1190.
218. Smith M.L., Lancia J.K., Mercer T.I., Ip C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res. 2004, 24:1401-1408.
219. Solakidi S., Psarra A.M.G., Nikolaropoulos S., Sekeris C.E. Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece. Hum. Reprod. 2005, 20:3481-3487.
220. Solakidi S., Psarra A.M.G., Sekeris C.E. Differential distribution of glucocorticoid and estrogen receptor isoforms: localization of GRbeta and ERalpha in nucleoli and GRalpha and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. J. Musculoskel. Neuronal Interact. 2007, 7:240-245.
221. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., Green D.R. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005, 310:66-67.
222. Spinazzola A., Zeviani M. Disorders of nuclear-mitochondrial intergenomic communication. Biosci. Rep. 2007, 27:39-51.
223. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., Patel M.S., Beal M.F. Mitochondrial a-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24:7779-7788.
224. Sterling K., Milch P.O. Thyroid hormone binding by a component of mitochondrial membrane. Proc. Natl. Acad. Sci. USA 1975, 72:3225-3229.
225. Sterling K., Lazarus J.H., Milch P.O., Sakurada T., Brenner M.A. Mitochondrial thyroid hormone receptor: localization and physiological significance. Science 1978, 201:1126-1129.
226. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10:1881-1896.
227. Storz P. Reactive oxygen species-mediated mitochondria-to-nucleus signaling: a key to aging and radical-caused diseases. Sci. STKE 2006, 332.
228. Storz P., Doppler H., Toker A. Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol. Cell. Biol. 2005, 25:8520-8530.
229. Sumitomo M., Ohba M., Asakuma J., Asano T., Kuroki T., Asano T., Hayakawa M. Protein kinase C delta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Invest. 2002, 109:827-836.
230. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 1996, 21:335-348.
231. Sun X.Z., Vinci C., Makmura L., Han S., Tran D., Nguyen J., Hamann M., Grazziani S., Sheppard S., Gutova M., Zhou F., Thomas J., Momand J. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid. Redox Signal. 2003, 5:655-665.
232. Takeshige K., Minakami S. NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochem. J. 1979, 180:129-135.
233. Tang Y., Luo J., Zhang W., Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 2006, 24:827-839.
234. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-induced, TNF-a-mediated central nervous system toxicity. Neurobiol. Dis. 2006, 23:127-139.
235. Tangpong J., Cole M.P., Sultana R., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J. Neurochem. 2007, 100:191-201.
236. Tangpong J., Sompol P., Vore M., St.Clair W.H., Butterfield D.A., St.Clair D.K. Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells. Neuroscience 2008, 151:622-629.
237. Thornborrow E.C., Patel S., Mastropietro A.E., Schwartzfarb E.M., Manfredi J.J. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 2002, 21:990-999.
238. Tokino T., Nakamura Y. The role of p53-target genes in human cancer. Crit. Rev. Oncol. Hematol. 2000, 33:1-6.
239. Trachootham D., Lu W., Ogasawara M.A., Rivera-del Valle N., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
240. Travan A., Wong J.M.S., Xu D., Sopta M., Ingles C.J. Altered nuclear gene expression profiles in a yeast mitochondrial DNA mutant. J. Biol. Chem. 2001, 276:4020-4027.
241. Tretter L., Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by a-ketoglutarate dehydrogenase. J. Neurosci. 2004, 24:7771-7778.
242. 1 complex. J. Biol. Chem. 1990, 265:11409-11412.
243. Van Remmen H., Salvador C., Yang H., Huang T.T., Epstein C.J., Richardson A. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Arch. Biochem. Biophys. 1999, 363:91-97.
244. van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.-T., Nelson J., Strong R., Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiolog. Genom. 2003, 16:29-37.
245. Velu C.S., Niture S.K., Doneanu C.E., Pattabiraman N., Srivenugopal K.S. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 2007, 46:7765-7780.
246. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H.J., Goswami P.C., Ritchie J.M., Oberley L.W., Buettner G.R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005, 24:77-89.
247. Vousden K.H. Outcomes of p53 activation-spoilt for choice. J. Cell Sci. 2006, 119:5015-5020.
248. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
249. Wang X., Martindale J.L., Liu Y., Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 1998, 333:291-300.
250. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5:14-21.
251. Weisiger R.A., Fridovich I. Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 1973, 248:4793-4796.
252. Wong T.S., Rajagopalan S., Townsley F.M., Freund S.M., Petrovich M., Loakes D., Fersht A.R. Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53. Nucleic Acids Res. 2009, 37:568-581.
253. Wright V.P., Reiser P.J., Clanton T.L. Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle. J. Physiol. 2009, 587:5767-5781.
254. Wu H.-H., Momand J. Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J. Biol. Chem. 1998, 273:18898-18905.
255. Yeo W.-S., Lee S.J., Lee J.R., Kim K.P. Nitrosative protein tyrosine modifications: biochemistry and functional significance. BMB Rep. 2008, 41:194-203.
256. Zamocky M., Furtmuller P.G., Obinger C. Evolution of catalases from bacteria to humans. Antioxid. Redox Signal. 2008, 10:1527-1547.
257. Zelko I.N., Mariani T.J., Felz R.J. Superoxide dismutase multigene family: a comparison of CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structure, evolution, and expression. Free Radic. Biol. Med. 2002, 33:337-349.
258. Zhang L., Yu L., Yu C.-A. Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J. Biol. Chem. 1998, 273:33972-33976.
259. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St.Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
260. Zhou Z., Kang Y.J. Cellular and subcellular localization of catalase in the heart of transgenic mice. J. Histochem. Cytochem. 2000, 48:585-594.
261. Zhou S., Kachhap S., Singh K.K. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 2003, 18:287-292.